Floatz logo

Cladribine

Acute Monocytic Leukemia

OHSU Knight Cancer InstituteSmall moleculePhase 2/3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Acute Monocytic Leukemia cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Stanford University
Phase 3BBB
Cytosin-Arabinosid
Chinese PLA General Hospital
Phase 3BBB
Daunorubicin
National Cancer Institute (NCI)
Phase 3BBB
Mitoxantrone
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2/3BBB
FILGRASTIM
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3BBB

View all 50 →

Same molecule, other indications

Cladribine is also rated in:

relapsing-remitting multiple sclerosisDormant
BBB
Indicative ·
76 / 100
View asset →
lymphoblastic lymphomaDormant
BBB
Indicative ·
75 / 100
View asset →
multiple sclerosisDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →